Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | H1₹6.76Admitted-Finance | ₹6.76 | H1 | Admitted-Finance |
| 2 | H2₹2.02−₹4.74 (70.1%)Admitted-Finance PLOT NO 2117 A 2 PHASE II II G I D C VAPI GUJARAT INDIA 396195 | VAPI | VALSAD | GUJARAT | 396195 | ₹2.02−₹4.74 (70.1%) | H2 | Admitted-Finance |
| 3 | H3₹1.89−₹4.87 (72.0%)Admitted-Finance | ₹1.89−₹4.87 (72.0%) | H3 | Admitted-Finance |
| 4 | H4₹1.85−₹4.91 (72.6%)Admitted-Finance | ₹1.85−₹4.91 (72.6%) | H4 | Admitted-Finance |
| 5 | Rejected-Technical SURVEY NO 144 A JAROD SAMLAYA ROAD VILL HARIPURA TAL SAVLI DIST VADODARA GUJARAT INDIA 391520 | VADODARA | VADODARA | GUJARAT | 391520 | - | - | Rejected-Technical As per uploaded summary |
| Sl No | Description | Qty | Unit | MYLAN LABORATORIES LIMITED H1 | MICRON PHARMACEUTICALS H2 | J.Duncan Healthcare Pvt. Ltd. H4 | Macleods Pharmaceuticals Ltd. H3 |
|---|---|---|---|---|---|---|---|
| 1.01 | Zidovudine 60 mg + Lamivudine 30 mg | 98,90,497 | Tablets | 2.27 ₹2.54 | 1.8 ₹2.02 | 1.65 ₹1.85 Lowest | - |
| 1.02 | Dolutegravir 10 mg | 1,42,82,386 | Tablets | 3.77 ₹4.22 | - | - | 1.69 ₹1.89 Lowest |
Tender Value
Refer Docs
EMD Value
₹1.8 L
Closing Date
6 Feb 2023, 3:00 pmClosed
DG and CEO, CMSS
CMSS Office, 2nd Floor, Vishwa Yuvak Kendra, Near Teen Murti Marg
Procurement of ARV Drugs For NACo for F.Y. 2022-23
2023_CMSS_733056_1
CMSS/PROC/2022-23/NACO/028
Open Tender
Drugs and Pharmaceutical Products
Supply
60 days
New Delhi
As per Tender
2 documents required · 2 mandatory
₹0
₹1.8 L
Yes
New Delhi
2 May 2023
4 Jan 2023
7 Feb 2023
4 Jan 2023
6 Feb 2023
10 Jan 2023
4 Jan 2023 - 9 Jan 2023
9 Jan 2023
Zidovudine 60 mg + Lamivudine 30 mg
Dolutegravir 10 mg
MICRON PHARMACEUTICALS
Macleods Pharmaceuticals Ltd.
J.Duncan Healthcare Pvt. Ltd.
2. Annex-I A
stage.html
html • 0.04 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .